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At school we all learned of the tale from Greek mythology of
Icarus, who while trying to escape from Crete ignored the
warnings of his father and ﬂew too close to the sun. His
wings of feather and wax melted and he fell to the sea, where
he drowned. This tale is often told as a warning of the perils
of overambition. It is ironic how our desire to advance new
approaches in cardiovascular medicine so commonly reaches
a similarly futile outcome.
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One such area that continues to stimulate our desire to
push the boundaries is the ability to visualize atherosclerotic
plaque in vivo. This has been stimulated by the fundamental
role played by atherosclerosis in the pathogenesis of ischemic
cardiovascular events. Although we have developed tools
enabling the visualization of coronary atheroma in vivo, we
have remained somewhat dissatisﬁed, convinced that there
must be more to the disease than depicted by more tradi-
tional methods of coronary imaging.
We have become increasingly focused on the role of the
“vulnerable plaque” underlying acute ischemic events, on the
basis of elegant reports from pathology studies. These
reports tell us that a large plaque containing lipid, inﬂam-
matory cells and necrotic debris, in association with a thin
ﬁbrous cap and positive arterial wall remodeling, represents
the typical plaque encountered at the culprit site in patients
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Steve Nissen, MD, served as Guest Editor for this paper.enormous interest in the development of imaging tools to
identify such lesions (3).
These reports have also described that not all acute events
are accompanied by areas of plaque rupture. Rather, in some
instances pathologists describe the presence of ﬁbrous cap
erosion overlying a plaque appearing less vulnerable in terms
of its histological phenotype (4). Although plaque erosion
seems to be more common in female subjects, younger
patients, and smokers, there remains little evolution in our
ability to image these lesions in vivo or to develop additional
biomarkers for more effective prediction of these events.
In parallel with increasing interest in the various plaque
phenotypes implicated in acute ischemic events, there have
been considerable technological advances in arterial wall
imaging. These techniques enable direct visualization of the
entire burden of atherosclerotic plaque within the artery
wall, with the potential to provide incremental plaque
characterization beyond measures of plaque burden. These
modalities have primarily focused on the demonstration of
features implicated in plaque vulnerability such as the
necrotic and lipid components of plaque. It remains to be
determined what role these techniques will play in clini-
cal practice or development of novel anti-atherosclerotic
therapies.
A recent advance in vascular imaging has witnessed the
use of optical coherence tomography (OCT), a light-based
modality that images the superﬁcial aspects of the vessel
wall with the highest resolution noted to date. As a result,
there has been a steep proliferation in the use of OCT in the
characterization of coronary artery disease in the catheteri-
zation laboratory. In addition to its role in aiding percuta-
neous coronary intervention, there is hope that it will also
provide important biological insights into the natural history
of atherosclerotic plaque in the artery wall.
In this issue of the Journal, Jia et al. (5) report the ﬁndings
of a systematic review of 126 patients who underwent
intracoronary OCT imaging before percutaneous coronary
intervention of a culprit lesion in the setting of an acute
coronary syndrome. Of particular interest, plaque erosions
were observed at the culprit site in nearly one-third of
patients. These individuals were younger and more likely to
present with non–ST-segment elevation myocardial infarc-
tions and whose culprit lesions contained smaller lipid pools,
thicker ﬁbrous caps, and less-severe diameter stenosis on
angiography.
These observations reﬂect an important addition to
our ability to characterize atherosclerotic plaque in vivo. For
the ﬁrst time, we seem to be able to reliably visualize plaque
erosion before the vessel ends up in the hands of the
pathologist. Or have we? The ﬁndings do need to be
considered with the caveat that they reﬂect observations
consistent with a consensus statement on how to interpret
OCT imaging, much of which is drawn from relatively
sparse histological validation. As with all new modalities that
propose to demonstrate plaque features beyond burden, we
must continue to ask ourselves to what degree are we
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present in the vessel? As the use of OCT will continue to
increase, we must ensure that there continues to be ongoing
validation of its observations (6).
Accepting that the features demonstrated on OCT do
accurately represent plaque characteristics that they are re-
ported to, what do we do with the ﬁndings? What are the
implications for the ability to image plaque erosions in the
catheterization laboratory? Does this change how we
manage patients in the acute setting or as a means of
secondary prevention? If it doesn’t, how does that inﬂuence
our interest in such imaging? Most importantly, our major
objective is to prevent these events from occurring in the ﬁrst
place. Are we any closer to being able to predict plaque
erosion, to triage patients to more aggressive preventive
therapies? Furthermore, can we detect serial changes in
response to novel anti-atherosclerotic agents, and are such
changes clinically meaningful? At least for now, the answer is
sadly “no.” Whether such advances actually change what we
do and ultimately what happens to patients remains to be
determined. However, such steps are vital if we are to seriously
integrate such imaging approaches into our research and
clinical armamentarium.
Arterial wall imaging with light-based techniques provides
a unique opportunity to advance our ability to characterize
atherosclerosis and its relationship to vascular risk. Our
challenge is to develop broad strategies that effectively advance
the utility of these ﬁndings rather than being too absorbedwith the “light,” while adding to an ever-growing pile of
cardiovascular advances that fail to advance the ﬁeld.
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